A Review On Nano-Advantage: Why Nano-Niosomes Are Gaining Preference Over Traditional Niosomes

Niosomes represent an innovative drug delivery mechanism where the therapeutic agent is enclosed within a vesicle. In terms of structure, niosomes mirror liposomes, both featuring a bilayer composition. However, niosomes diverge from liposomes in that their bilayer is constructed from non-ionic surfactants, as opposed to the phospholipids typical of liposomes. While most surfactants form micellar patterns in water, certain ones can form bilayer vesicles, termed niosomes. In the continually advancing domain of drug delivery, nanoniosomes have marked a notable progression beyond conventional niosomes. This analytical piece highlights the swift rise of nanoniosomes, underscoring their enhanced characteristics, propelling them to the forefront of contemporary therapeutic innovations. While traditional niosomes are lauded for their encapsulation potential and biocompatibility, their nano-sized counterparts, nanoniosomes, promise increased absorption, superior bioavailability, and precision targeting. Their adeptness in encapsulating a broad spectrum of drugs, be it water-soluble or lipid-based, positions nanoniosomes as a pivotal instrument in the realm of tailored medical treatments. Through an in-depth examination of their merits and practical applications, this analysis clarifies the potential of nanoniosomes to eclipse niosomes in the modern drug delivery landscape. As the demand for more effective drug delivery systems grows, nano-niosomes stand out for their potential to provide safer, more effective, and more patient-friendly therapies, signifying a major leap forward in personalized medicine and sustained drug delivery. The ongoing advancements in nanofabrication techniques are expected to further bolster the scalability and commercial viability of nano-niosomes, paving the way for their widespread adoption in clinical applications.